Exhibiting at VIV Asia 2025

Guangzhou Haicheng Pharmaceutical Co., Ltd., headquartered in Guangzhou, China, is a nationally recognized manufacturer and supplier of veterinary pharmaceuticals, feed additives, and active pharmaceutical ingredients (APIs). With a firm foundation in veterinary science and modern feed technology, the company has positioned itself as a reliable partner in the global animal health and nutrition industry.

Core Business and Product Portfolio

Haicheng Pharmaceutical offers a comprehensive product portfolio targeting disease prevention, growth promotion, and nutritional enhancement in livestock and poultry. Its main categories include:

• Anticoccidial Products

  • Clopidol, Robenidine Hydrochloride, Dinitolmide: Broad-spectrum anticoccidials used to prevent and treat Eimeria spp. infections in poultry production systems.

• Feed Enzymes

  • Protease, Cellulase, Xylanase: Enhance feed digestibility, reduce feed cost, and improve nutrient uptake in monogastric animals.

• Probiotics

  • Bacillus subtilis, Bacillus licheniformis, Enterococcus faecium: Improve gut health, competitive exclusion of pathogens, and immune modulation.

• Selenium Yeast

  • Organic selenium source used in improving antioxidant capacity and reproductive performance in livestock.

• Amino Acids

  • L-Threonine, L-Tryptophan: Essential amino acids used in precision nutrition formulas to optimize protein synthesis and growth rates.

• APIs (Active Pharmaceutical Ingredients)

  • Enramycin, Colistin Sulfate: Widely used veterinary-grade APIs for formulation of oral and premix antibiotics.

These products are tailored for use in poultry, swine, ruminants, and aquaculture, meeting both domestic and international formulation standards.

Scientific Strength and R&D Innovation

Haicheng Pharmaceutical operates an in-house R&D center staffed with experienced microbiologists, pharmacologists, and feed technologists. The company’s R&D competencies include:

• Development of stable, heat-tolerant enzyme blends for pelleted feeds
• Strain improvement programs for probiotic and microbial products
• Quality standard establishment for veterinary API specifications
• Collaborative research with leading Chinese veterinary and agricultural universities

R&D outputs directly support product customization, regulatory registrations, and efficacy trials.

Manufacturing Infrastructure and Quality Control

Haicheng operates GMP-certified production lines for veterinary drugs, APIs, and feed additives. Key infrastructure includes:

• Fermentation facilities for probiotic and enzyme production
• Chemical synthesis units for anticoccidial agents and APIs
• Spray drying and microencapsulation lines for product stability
• Analytical QC labs equipped with HPLC, UV spectrophotometers, and microbial assay facilities

All production batches are subjected to stringent quality testing and traceability protocols, ensuring compliance with both Chinese and international pharmacopeias.

Global Reach and Export Activity

Haicheng Pharmaceutical has established itself in the global market through consistent product performance and compliance with international regulatory standards. According to trade data from Volza and ImportYeti:

• The company has executed over 180 international shipments in the past three years.
• Key export markets include Vietnam, India, Bangladesh, Nigeria, Egypt, and Pakistan.
• Exported products primarily include anticoccidial APIs, probiotics, and amino acids.
• Estimated annual export revenue ranges between $8 million to $12 million, reflecting steady international demand for its veterinary formulations.

Haicheng maintains partnerships with local distributors and veterinary drug manufacturers, expanding its reach in both emerging and regulated markets.

Customer Base and Industry Applications

Haicheng’s products are widely used by:

• Veterinary drug formulation companies
• Feed millers and premix manufacturers
• Poultry and swine integrators
• Animal health distributors

These products are essential in both preventive and performance-enhancing applications, contributing to improved animal productivity and reduced disease incidence.

Regulatory Compliance and Certifications

Haicheng adheres to international standards of manufacturing and safety through:

• Veterinary GMP certification issued by the Ministry of Agriculture and Rural Affairs of China
• ISO 9001:2015 Quality Management System
• HACCP implementation across feed-grade product lines
• DMF (Drug Master File) support for APIs in regulated markets
• Registration dossiers filed in multiple export destinations under local veterinary regulatory agencies

The company’s robust documentation and compliance systems enable smooth international market access and audit readiness.

Reputation and Industry Presence

Haicheng Pharmaceutical is a frequent participant in industry exhibitions such as:

• VIV Asia
• IPPE USA
• China Feed Expo
• CPhI China

These platforms enable direct engagement with international buyers and regulators, reinforcing its brand as a reliable and technically proficient supplier.

Key Achievements

• Developed and commercialized six key anticoccidial APIs for poultry use
• Supplied feed enzyme blends and probiotics to over 300 feed manufacturers in China and abroad
• Exported products to 30+ countries, supporting local disease management programs
• Achieved zero major non-compliance issues in international audits and certifications
• Continues to invest in green production practices and biosafety R&D

Guangzhou Haicheng Pharmaceutical Co., Ltd. stands out as a scientifically driven and export-oriented pharmaceutical enterprise, delivering critical veterinary and feed solutions that support modern, efficient, and safe animal agriculture globally.